1. Immunogenicity and safety of an enterovirus 71 vaccine in children aged 36-71 months: A double-blind, randomised, similar vaccine-controlled, non-inferiority phase III trial. (October 2022) Authors: Tong, Yeqing; Zhang, Xinyue; Chen, Jinhua; Chen, Wei; Wang, Zhao; Li, Qiong; Duan, Kai; Wei, Sheng; Yang, Beifang; Qian, Xiaoai; Li, Jiahong; Hang, Lianju; Deng, Shaoyong; Li, Xinguo; Guo, Changfu; Shen, Heng; Liu, Yan; Deng, Peng; Xie, Tingbo; Li, Qingliang Journal: EClinicalMedicine Issue: Volume 52(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗